IMAC - IMAC Holdings, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
3.8800
-0.1700 (-4.20%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close4.0500
Open4.0500
Bid3.0000 x 1000
Ask5.3500 x 800
Day's Range3.8800 - 4.2000
52 Week Range2.6000 - 7.2050
Volume42,438
Avg. Volume12,007
Market Cap32.618M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.9380
Earnings DateAug 16, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire

    IMAC Holdings Second Quarter 2019 Financial Results Feature Continued Significant Revenue Increase

    BRENTWOOD, Tenn, Aug. 16, 2019 -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of Innovative Medical Advancements and Care, specializing in.

  • GlobeNewswire

    IMAC’s BioFirma Subsidiary Announces Registered Status with U.S. Food and Drug Administration

    IMAC Holdings, Inc. (IMAC), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, announces its BioFirma subsidiary has received “Registered” status with the U.S. Food and Drug Administration (FDA). IMAC is now using BioFirma’s NeoCyte® regenerative medicine products in its rehabilitation clinics. Ian White, Ph.D., the company's chief scientific officer, and president of BioFirma was recently featured in the docuseries Pain Revealed where he highlighted opportunities of regenerative medicine that he has researched in his career.

  • GlobeNewswire

    IMAC’s Chief Scientific Officer Discusses the Company’s Approach to Treating Pain in Documentary Series Pain Revealed

    IMAC Holdings, Inc. (IMAC), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, announces that Ian White, Ph.D., the Company's chief scientific officer, is featured in Episode 3 of the nine-episode documentary series Pain Revealed. This two-hour episode can be viewed at painrevealed.com and Dr. White's portion starts at 3:25 and continues through 48:35. The series is co-hosted by Dr. Patrick Gentempo, a chiropractor and the founder and CEO of Action Potential Holdings, Inc, and co-founder, CEO and host of Revealed Films, Inc.

  • What Kind Of Shareholder Owns Most IMAC Holdings, Inc. (NASDAQ:IMAC) Stock?
    Simply Wall St.

    What Kind Of Shareholder Owns Most IMAC Holdings, Inc. (NASDAQ:IMAC) Stock?

    The big shareholder groups in IMAC Holdings, Inc. (NASDAQ:IMAC) have power over the company. Insiders often own a...

  • GlobeNewswire

    IMAC HOLDINGS FEATURED AT 2019 HEALTH CARE BENEFITS SUMMIT IN MEMPHIS

    BRENTWOOD, Tenn, June 20, 2019 (GLOBE NEWSWIRE) --  IMAC Holdings, Inc. (IMAC) (“IMAC” or the “Company”), a provider of Innovative Medical Advancements and Care, specializing in regenerative and rehabilitation orthopedic treatments without the use of surgery or opioids, announces participation in the Validation Institute’s 2019 Health Care Benefits Summit held yesterday at the FedEx Institute of Technology in Memphis. Matthew Wallis, cofounder and chief operating officer, presented the value proposition IMAC Regeneration Centers offers to self-funded companies and other payers, given the Company’s advanced approach to treating musculoskeletal conditions.

  • GlobeNewswire

    IMAC HOLDINGS UPGRADES SPRINGFIELD, MISSOURI CLINICS

    IMAC Holdings, Inc. (IMAC) (“IMAC” or the “Company”), a provider of Innovative Medical Advancements and Care, specializing in regenerative and rehabilitation orthopedic treatments without the use of surgery or opioids, announces new, upgraded Ozzie Smith IMAC Regeneration Centers in the Springfield, Missouri area. The Company has relocated its Ozark, Missouri clinic into a 2,700 square foot state-of-the-art facility, from its previous 900 square foot facility. This new, larger facility allows IMAC to offer additional treatment options to more patients, with services overseen by a medical professional with a staff of licensed physical therapists.

  • GlobeNewswire

    IMAC HOLDINGS ANNOUNCES FAVORABLE NEW LONG-TERM OUTCOMES DATA FROM REGENERATIVE REHABILITATION FOR MUSCULOSKELETAL CONDITIONS

    Data collection averaged 17.3 months post-treatment with an average patient age of 61.7 years. Patients completed care at least 11 months and at most 25 months prior to the data collection date. “This outcomes data provides compelling support for our combined regenerative and rehabilitative treatments, which provide patients an alternative to surgery and opioids for the treatment of pain,” said Matthew Wallis, cofounder and chief operating officer of IMAC.

  • ACCESSWIRE

    IMAC Holdings to Present at the 9th Annual LD Micro Invitational

    BRENTWOOD, TN / ACCESSWIRE / May 23, 2019 / IMAC Holdings, Inc. (NASDAQ: IMAC) , a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments ...

  • GlobeNewswire

    IMAC Holdings First Quarter 2019 Financial Results Feature Significant Revenue Increase

    BRENTWOOD, Tenn, May 15, 2019 -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of Innovative Medical Advancements and Care, specializing in.

  • GlobeNewswire

    IMAC Holdings Reports 2018 Financial Results; Significant Revenue Growth Reflects Addition of Five Clinics During the Year

    BRENTWOOD, Tenn., April 17, 2019 -- IMAC Holdings, Inc. (Nasdaq: IMAC), a provider of Innovative Medical Advancements and Care, specializing in regenerative rehabilitation.

  • GlobeNewswire

    IMAC Holdings Enters Greater Chicago Market with Acquisition; Will Rebrand as Mike Ditka IMAC Regeneration Centers

    BRENTWOOD, Tenn, April 02, 2019 (GLOBE NEWSWIRE) --  IMAC Holdings, Inc. (IMAC), a provider of innovative medical advancements and care, specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, announces the signing of a merger agreement to acquire ISDI Holdings, Inc. (“ISDI”), a practice management group that manages three clinics in the Chicago area. Under the terms of the merger agreement, IMAC will issue 1,002,306 shares of common stock at closing, which is expected to occur in the second quarter of 2019 following the satisfaction of certain conditions included in the merger agreement. Pursuant to the merger agreement, ISDI Holdings, Inc., the parent company of the Chicago clinics’ management, will merge with and into IMAC’s wholly-owned subsidiary IMAC Management of Illinois, LLC. IMAC expects to identify approximately $50,000 of annual cost synergies in connection with the merger.

  • GlobeNewswire

    IMAC Holdings to Present at The MicroCap Conference Spring Investor Summit

    BRENTWOOD, Tenn, March 28, 2019 -- IMAC Holdings, Inc. (Nasdaq: IMAC), a provider of Innovative Medical Advancements and Care, specializing in regenerative rehabilitation.

  • GlobeNewswire

    IMAC Holdings Reports 2018 Fourth Quarter and Year-end Patient Visits and Procedure Volume Featuring Double-digit Increases

    All figures listed below for all periods are noted as either actual or pro forma.  Actual procedure and visit counts are inclusive of actual patient visits and procedures for all clinics owned or managed by IMAC Holdings during the period. Pro Forma procedure and visit counts reflect the completion of our transactions consummated through December 31, 2018 as if they had occurred on January 1, 2017.

  • GlobeNewswire

    IMAC Engages Legendary Football Player and Coach Mike Ditka as Brand Ambassador for the Chicago Area

    IMAC Holdings, Inc. (IMAC), a provider of Innovative Medical Advancements and Care, specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, announces that Mike Ditka has been engaged to serve as brand ambassador for the Company’s planned expansion into the Chicago market. Mr. Ditka, a three-time Super Bowl champion and 11-year coach of the Chicago Bears, joins other IMAC iconic brand ambassadors including Tony Delk, Ozzie Smith and David Price to bring awareness to IMAC’s conservative approach to treating mobility impairments.

  • GlobeNewswire

    IMAC Establishes Dedicated Corporate Accounts Division; Broadens Positioning of Product Offerings to Provide Innovative Medical Advancements and Care

    IMAC Holdings, Inc. (IMAC), a provider of Innovative Medical Advancements and Care, specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, announces the establishment of a dedicated corporate accounts division: IMAC Regeneration Centers Corporate Partnerships. This division will focus on partnerships with self-funded employers seeking to provide employees with non-surgical solutions to spine, knee, hip, shoulder and other musculoskeletal conditions at a significant cost savings compared to surgery. Laura Fristoe, who joined IMAC in 2016 as Director of Business Development, has been named Vice President, Corporate Partnerships and will lead this initiative.

  • GlobeNewswire

    IMAC to Ring Opening Bell at Nasdaq MarketSite in Celebration of IPO on February 20th

    Mr. Ervin will be joined by members of the IMAC management team and brand ambassador partners, Tony Delk, former professional basketball player and Ozzie Smith, former professional baseball player and hall-of-famer. “The ringing of the opening bell is an exciting way to begin our journey as a publicly traded company and we are honored to have this opportunity,” said Jeff Ervin.

  • GlobeNewswire

    Dawson James Securities Announces the Closing of IMAC Holdings, Inc. NASDAQ Initial Public Offering at $5.125 per Unit

    Dawson James Securities, Inc. in conjunction with IMAC Holdings, Inc. (IMAC) announced today the closing of its firm commitment underwritten Initial Public Offering of 850,000 Units, with each unit consisting of one share of common stock and two warrants to purchase one share of common stock, at a combined price of $5.125 per unit.  The exercise price of the warrants is $5.00 per warrant and expire in February 2024.  The units separated immediately and trade under the respective NASDAQ ticker symbols of IMAC and IMACW. A registration statement on Form S-1 relating to this offering was filed with the Securities and Exchange Commission (“SEC”) and was declared effective by the SEC on February 12, 2019.

  • Brentwood health care company goes public
    American City Business Journals

    Brentwood health care company goes public

    IMAC Holdings Inc. is offering 850,000 shares at $5 per share on the The Nasdaq Capital Market in an effort to raise $4.25 million.

  • GlobeNewswire

    IMAC Holdings Prices 850,000 Unit Firm Commitment Initial Public Offering

    IMAC Holdings, Inc. (IMAC), a provider of regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, announced today the pricing of its firm commitment underwritten initial public offering of 850,000 units, with each unit consisting one share of common stock and two warrants each to purchase one share of common stock, at a combined initial public offering price of $5.125 per unit. The exercise price of the warrants is $5.00 per warrant.  The units will immediately and automatically separate upon issuance, and the common stock and warrants will begin trading today on The NASDAQ Capital Market under the ticker symbols “IMAC” and “IMACW,” respectively. The Company expects to receive aggregate gross proceeds of $4,356,250 from this offering, before deducting underwriting discounts, commissions and other related expenses.